Pulmonx Co. (NASDAQ:LUNG) Receives $12.75 Consensus Price Target from Analysts
Pulmonx Co. (NASDAQ:LUNG – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among […]
Pulmonx Co. (NASDAQ:LUNG – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price target among […]
